Junran Zhang

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Venues

Research square

Cancer research

Breast cancer research : BCR

Cancers

The Ohio State University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The Ohio State University Feb 15o 2018

United States

Associate Professor :: Radiation Oncology

Publications

Junran Zhang, Chandra Prasad, Adrian Oo, Zhaojun Qiu, Na Li, Deepika Singh, Xiwen Xin, Young-Jae Cho, Zaibo Li, Xiaoli Zhang, Chunhong Yan, Qingfei Zheng, Jimin Shao, Hongbing Wang, Baek Kim
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity. Research square (2023)
Junran Zhang, Chandra Prasad, Adrian Oo, Zhaojun Qiu, Na Li, Deepika Singh, Xiwen Xin, Young-Jae Cho, Zaibo Li, Xiaoli Zhang, Chunhong Yan, Qingfei Zheng, Jimin Shao, Hongbing Wang, Baek Kim
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity. Research square (2023)
Rita A Avelar, Amy J Armstrong, Gracie Carvette, Riya Gupta, Noah Puleo, Jose A Colina, Peronne Joseph, Alexander M Sobeck, Caitlin M O'Connor, Brynne Raines, Agharnan Gandhi, Michele L Dziubinski, Daniel S Ma, Kimberly Resnick, Sareena Singh, Kristine Zanotti, Christa Nagel, Steven Waggoner, Dafydd G Thomas, Stephanie L Skala, Junran Zhang, Goutham Narla, Analisa DiFeo
Small molecule mediated stabilization of PP2A modulates the Homologous Recombination pathway and potentiates DNA damage-induced cell death. Molecular cancer therapeutics (2023)
Danyal Daneshdoust, Mingjue Luo, Zaibo Li, Xiaokui Mo, Sahar Alothman, Bhaskar Kallakury, Richard Schlegel, Junran Zhang, Deliang Guo, Priscilla A Furth, Xuefeng Liu, Jenny Li
Unlocking Translational Potential: Conditionally Reprogrammed Cells in Advancing Breast Cancer Research. Cells 12 (19) (2023)
Zhipeng Hong, Tao Liu, Lingfeng Wan, Pengyan Fa, Pankaj Kumar, Yanan Cao, Chandra Bhushan Prasad, Zhaojun Qiu, Joseph Liu, Hongbing Wang, Zaibo Li, Hongbing Wang, Peixuan Guo, Deliang Guo, Ayse S Yilmaz, Lanchun Lu, Ioanna Papandreou, Naduparambil K Jacob, Chunhong Yan, Xiaoli Zhang, Qing-Bai She, Zhefu Ma, Junran Zhang
Targeting Squalene Epoxidase Interrupts Homologous Recombination via the ER Stress Response and Promotes Radiotherapy Efficacy. Cancer research 82 (7) (2022)
Ananya Banerjee, Shurui Cai, Guozhen Xie, Na Li, Xuetao Bai, Kousalya Lavudi, Kevin Wang, Xiaoli Zhang, Junran Zhang, Srinivas Patnaik, Floor J Backes, Chad Bennett, Hongbing Wang
A Novel Estrogen Receptor β Agonist Diminishes Ovarian Cancer Stem Cells via Suppressing the Epithelial-to-Mesenchymal Transition. Cancers 14 (9) (2022)
Zhaojun Qiu, Pengyan Fa, Tao Liu, Chandra Bhushan Prasad, Shanhuai Ma, Zhipeng Hong, Ernest Ricky Chan, Hongbing Wang, Zaibo Li, Kai He, Terence M Williams, Chunhong Yan, Steven T Sizemore, Goutham Narla, Junran Zhang
A Genome-Wide Pooled shRNA Screen Identifies PPP2R2A as a Predictive Biomarker for the Response to ATR and CHK1 Inhibitors. Cancer research 80 (16) (2020)
Lingfeng Wan, Tao Liu, Zhipeng Hong, You Pan, Steven T Sizemore, Junran Zhang, Zhefu Ma
NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis. Breast cancer research : BCR 21 (1) (2019)

Junran Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Junran Zhang